Copyright Reports & Markets. All rights reserved.

Global Gastroesophageal Reflux Disease Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Gastroesophageal Reflux Disease Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Antacids
    • 1.4.3 H2 Receptor Blockers
    • 1.4.4 Proton Pump Inhibitors (PPIs)
    • 1.4.5 Pro-kinetic Agents
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Drug Stores
    • 1.5.4 General Stores
    • 1.5.5 Supermarkets
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Gastroesophageal Reflux Disease Therapeutics Growth Trends by Regions
    • 2.2.1 Gastroesophageal Reflux Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Gastroesophageal Reflux Disease Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Gastroesophageal Reflux Disease Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Gastroesophageal Reflux Disease Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Market Size
    • 3.1.1 Global Top Gastroesophageal Reflux Disease Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Gastroesophageal Reflux Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio
    • 3.2.1 Global Gastroesophageal Reflux Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Gastroesophageal Reflux Disease Therapeutics Revenue in 2019
  • 3.3 Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Gastroesophageal Reflux Disease Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Gastroesophageal Reflux Disease Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Gastroesophageal Reflux Disease Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Gastroesophageal Reflux Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 6.2 Gastroesophageal Reflux Disease Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 7.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 8.2 Gastroesophageal Reflux Disease Therapeutics Key Players in China (2019-2020)
  • 8.3 China Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 9.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 10.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 11.2 Gastroesophageal Reflux Disease Therapeutics Key Players in India (2019-2020)
  • 11.3 India Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Gastroesophageal Reflux Disease Therapeutics Market Size (2015-2020)
  • 12.2 Gastroesophageal Reflux Disease Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 AstraZeneca
    • 13.1.1 AstraZeneca Company Details
    • 13.1.2 AstraZeneca Business Overview
    • 13.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.1.4 AstraZeneca Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020))
    • 13.1.5 AstraZeneca Recent Development
  • 13.2 Eisai
    • 13.2.1 Eisai Company Details
    • 13.2.2 Eisai Business Overview
    • 13.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.2.4 Eisai Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.2.5 Eisai Recent Development
  • 13.3 Takeda Pharmaceutical
    • 13.3.1 Takeda Pharmaceutical Company Details
    • 13.3.2 Takeda Pharmaceutical Business Overview
    • 13.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.3.4 Takeda Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.3.5 Takeda Pharmaceutical Recent Development
  • 13.4 GlaxoSmithKline
    • 13.4.1 GlaxoSmithKline Company Details
    • 13.4.2 GlaxoSmithKline Business Overview
    • 13.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.4.4 GlaxoSmithKline Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.4.5 GlaxoSmithKline Recent Development
  • 13.5 Johnson & Johnson
    • 13.5.1 Johnson & Johnson Company Details
    • 13.5.2 Johnson & Johnson Business Overview
    • 13.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.5.4 Johnson & Johnson Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.5.5 Johnson & Johnson Recent Development
  • 13.6 Daewoong Pharmaceutical
    • 13.6.1 Daewoong Pharmaceutical Company Details
    • 13.6.2 Daewoong Pharmaceutical Business Overview
    • 13.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.6.4 Daewoong Pharmaceutical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.6.5 Daewoong Pharmaceutical Recent Development
  • 13.7 Ironwood Pharmaceuticals
    • 13.7.1 Ironwood Pharmaceuticals Company Details
    • 13.7.2 Ironwood Pharmaceuticals Business Overview
    • 13.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.7.4 Ironwood Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.7.5 Ironwood Pharmaceuticals Recent Development
  • 13.8 Rottapharm Madaus
    • 13.8.1 Rottapharm Madaus Company Details
    • 13.8.2 Rottapharm Madaus Business Overview
    • 13.8.3 Rottapharm Madaus Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.8.4 Rottapharm Madaus Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.8.5 Rottapharm Madaus Recent Development
  • 13.9 Peer Medical
    • 13.9.1 Peer Medical Company Details
    • 13.9.2 Peer Medical Business Overview
    • 13.9.3 Peer Medical Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.9.4 Peer Medical Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.9.5 Peer Medical Recent Development
  • 13.10 Reviva Pharmaceuticals
    • 13.10.1 Reviva Pharmaceuticals Company Details
    • 13.10.2 Reviva Pharmaceuticals Business Overview
    • 13.10.3 Reviva Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Introduction
    • 13.10.4 Reviva Pharmaceuticals Revenue in Gastroesophageal Reflux Disease Therapeutics Business (2015-2020)
    • 13.10.5 Reviva Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Gastroesophageal Reflux Disease Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastroesophageal Reflux Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    AstraZeneca
    Eisai
    Takeda Pharmaceutical
    GlaxoSmithKline
    Johnson & Johnson
    Daewoong Pharmaceutical
    Ironwood Pharmaceuticals
    Rottapharm Madaus
    Peer Medical
    Reviva Pharmaceuticals

    Market segment by Type, the product can be split into
    Antacids
    H2 Receptor Blockers
    Proton Pump Inhibitors (PPIs)
    Pro-kinetic Agents
    Others
    Market segment by Application, split into
    Hospital Pharmacy
    Drug Stores
    General Stores
    Supermarkets

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now